As mentioned in the current review, isocaloric TRE, particularly in individuals with prediabetes, improves fasting insulin and insulin resistance independent of weight loss [50], but with a controversy on the glucose profile in participants scheduled for ad libitum TRE who do not have diabetes [51–54]. The gene discussed is INS; the disease is Insulin resistance.